Uterin spindle cell mesenchymal neoplazm, NTRK fusion-positive uterine sarcoma

被引：0
|
作者：
Konuk, B. [1 ]
Topal, C. S. [1 ]
机构：
[1] Umraniye EducationTraining Hosp, Umraniye Istanbul, Turkey
来源：
VIRCHOWS ARCHIV | 2022年 / 481卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-09-03
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [31] Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer
    Frehner, Lorenz
    Haefliger, Simon
    Cerciello, Ferdinando
    Grob, Tobias
    Schmid, Sabine
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 871 - 877
  • [32] How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
    Ekman, Simon
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2535 - 2544
  • [33] Progression free survival of larotrectinib in patients with NTRK fusion-positive tumors: a systematic review
    Sumampow, M. M. A.
    Fu, R. C. E.
    Delvino, D.
    Albert, N.
    Danisha, P. A. C.
    Satcitta, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1353 - S1353
  • [34] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 36 - 37
  • [35] The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer
    Worst, M. A.
    Carothers, A.
    Surducan, M.
    Sipos, J.
    Wirth, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E50 - E51
  • [36] ADJUVANT LAROTRECTINIB THERAPY IN TWO CHILDREN WITH POOR PROGNOSIS NTRK FUSION-POSITIVE CANCERS
    Febres, Maria Carter
    Schneller, Netta
    Fair, Douglas
    Putnam, Angelica
    Linscott, Luke
    Bruggers, Carol
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S129 - S130
  • [37] Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
    Eszlinger, Markus
    Stewardson, Paul
    McIntyre, John B.
    Box, Adrian
    Khalil, Moosa
    Hyrcza, Martin
    Koro, Konstantin
    Ruether, Dean
    Wu, Jiahui
    Paschke, Ralf
    EUROPEAN THYROID JOURNAL, 2022, 11 (01)
  • [38] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien Billy
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 36 - 37
  • [39] Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report
    Tadipatri, Ramya
    Eschbacher, Jennifer
    Fonkem, Ekokobe
    Kresl, John
    Azadi, Amir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [40] Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome
    Yun, Karen M.
    Narezkina, Anna
    Redfern, Charles
    Velasco, Katherine
    Bazhenova, Lyudmila
    JCO PRECISION ONCOLOGY, 2024, 8
12345